Published in Am J Cardiol on June 01, 1976
Neuraxial modulation for refractory ventricular arrhythmias: value of thoracic epidural anesthesia and surgical left cardiac sympathetic denervation. Circulation (2010) 2.26
Long-QT syndrome: from genetics to management. Circ Arrhythm Electrophysiol (2012) 2.24
Genotype- and phenotype-guided management of congenital long QT syndrome. Curr Probl Cardiol (2013) 1.01
Power spectral analysis of heart rate variability during positive pressure pneumoperitoneum: the significance of increased cardiac sympathetic expression. Surg Endosc (2002) 0.95
Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome. Clin Res Cardiol (2012) 0.94
Videoscopic left cardiac sympathetic denervation for patients with recurrent ventricular fibrillation/malignant ventricular arrhythmia syndromes besides congenital long-QT syndrome. Circ Arrhythm Electrophysiol (2012) 0.93
Surgical left cardiac sympathetic denervation for long QT syndrome: effects on QT interval and heart rate. Heart Vessels (2005) 0.92
Left stellate ganglion block for continuous ventricular arrhythmias during percutaneous left ventricular assist device support. Tex Heart Inst J (2011) 0.90
The autonomic nervous system--a role in sudden infant death syndrome. Arch Dis Child (1992) 0.90
Cardiovascular changes after bilateral upper dorsal sympathectomy. Short- and long-term effects. Ann Surg (1986) 0.90
Percutaneous stellate ganglion block suppressing VT and VF in a patient refractory to VT ablation. J Cardiovasc Electrophysiol (2013) 0.88
Bilateral cardiac sympathetic denervation: why, who and when? Expert Rev Cardiovasc Ther (2012) 0.84
QT time in patients treated with alprenolol or placebo after myocardial infarction. Br Heart J (1979) 0.83
Cardiovascular disease and its association with histological changes of the left stellate ganglion. Clin Med Insights Pathol (2010) 0.83
Asymmetry of cardiac [123I] meta-iodobenzyl-guanidine scans in patients with ventricular tachycardia and a "clinically normal" heart. Br Heart J (1993) 0.82
Targeted ablation of cardiac sympathetic neurons reduces resting, reflex and exercise-induced sympathetic activation in conscious rats. Am J Physiol Heart Circ Physiol (2009) 0.82
Targeted ablation of cardiac sympathetic neurons reduces the susceptibility to ischemia-induced sustained ventricular tachycardia in conscious rats. Am J Physiol Heart Circ Physiol (2010) 0.80
Renal sympathetic denervation for treatment of ventricular arrhythmias: a review on current experimental and clinical findings. Clin Res Cardiol (2015) 0.79
Cardiac spinal deafferentation reduces the susceptibility to sustained ventricular tachycardia in conscious rats. Am J Physiol Regul Integr Comp Physiol (2011) 0.78
Renal denervation decreases effective refractory period but not inducibility of ventricular fibrillation in a healthy porcine biomodel: a case control study. J Transl Med (2015) 0.77
Pharmacological and non-pharmacological management of the congenital long QT syndrome: the rationale. Pharmacol Ther (2011) 0.77
Impaired neural structure and function contributing to autonomic symptoms in congenital central hypoventilation syndrome. Front Neurosci (2015) 0.76
Ionotropic glutamate receptors in the external lateral parabrachial nucleus participate in processing cardiac sympathoexcitatory reflexes. Am J Physiol Heart Circ Physiol (2012) 0.76
Left cardiac sympathetic denervation: An important treatment option for patients with hereditary ventricular arrhythmias. J Arrhythm (2015) 0.75
Left stellate ganglionectomy for the long Q-T interval syndrome: nine-year follow-up of a patient. Tex Heart Inst J (1982) 0.75
Management of Patients with Long QT Syndrome. Korean Circ J (2016) 0.75
Efficacy of bilateral thoracoscopic sympathectomy in a patient with catecholaminergic polymorphic ventricular tachycardia. J Arrhythm (2015) 0.75
Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation (2000) 7.50
Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet (1996) 7.35
Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease. Lancet (1993) 5.43
The calcium current of Helix neuron. J Gen Physiol (1978) 5.18
Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation (2000) 5.09
Spermine and spermidine as gating molecules for inward rectifier K+ channels. Science (1994) 4.82
Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation (1995) 4.48
A novel potassium channel with delayed rectifier properties isolated from rat brain by expression cloning. Nature (1989) 3.99
The long QT syndrome. Prospective longitudinal study of 328 families. Circulation (1991) 3.99
ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation (1995) 3.79
The long Q-T syndrome. Am Heart J (1975) 3.75
In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenesis. Infect Immun (1995) 3.56
The future of general practice in Newcastle upon Tyne. Lancet (1986) 3.47
Properties of internally perfused, voltage-clamped, isolated nerve cell bodies. J Gen Physiol (1978) 3.44
Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med (1998) 3.41
QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation (1978) 3.32
Receptor-effector coupling by G proteins. Biochim Biophys Acta (1990) 3.31
Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc Natl Acad Sci U S A (1984) 3.25
Calcium current-dependent and voltage-dependent inactivation of calcium channels in Helix aspersa. J Physiol (1981) 3.23
Low penetrance in the long-QT syndrome: clinical impact. Circulation (1999) 3.14
Exchange of conduction pathways between two related K+ channels. Science (1991) 3.09
Expression of Wnt-1 in PC12 cells results in modulation of plakoglobin and E-cadherin and increased cellular adhesion. J Cell Biol (1993) 2.95
Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation (2000) 2.95
Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J (2001) 2.93
Cardiac Na currents and the inactivating, reopening, and waiting properties of single cardiac Na channels. J Gen Physiol (1985) 2.93
Gating of inwardly rectifying K+ channels localized to a single negatively charged residue. Nature (1994) 2.91
A physical and genetic map of the IncN plasmid R46. Plasmid (1981) 2.86
Sodium current in single rat heart muscle cells. J Physiol (1981) 2.83
Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families. Circulation (2000) 2.81
Exercise training confers anticipatory protection from sudden death during acute myocardial ischemia. Circulation (1994) 2.79
Transformation by Wnt family proteins correlates with regulation of beta-catenin. Cell Growth Differ (1997) 2.74
Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS. Circulation (1996) 2.70
Idiopathic long QT syndrome: progress and questions. Am Heart J (1985) 2.59
A G protein directly regulates mammalian cardiac calcium channels. Science (1987) 2.58
Interprofessional collaboration in primary health care. J R Coll Gen Pract (1987) 2.56
Evidence for high-energy extraterrestrial neutrinos at the IceCube detector. Science (2013) 2.56
Heterologous regulation of the cardiac Ca2+ channel alpha 1 subunit by skeletal muscle beta and gamma subunits. Implications for the structure of cardiac L-type Ca2+ channels. J Biol Chem (1991) 2.55
Note on the nitrogen content of certain proteins. Biochem J (1932) 2.54
Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation (1998) 2.53
Direct activation of mammalian atrial muscarinic potassium channels by GTP regulatory protein Gk. Science (1987) 2.50
Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation (2001) 2.50
Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels. J Pharmacol Exp Ther (2000) 2.47
HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine. Circulation (1996) 2.46
Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res (1991) 2.41
Early outward current in rat single ventricular cells. Circ Res (1984) 2.41
Inactivation determined by a single site in K+ pores. Pflugers Arch (1993) 2.37
A retrovirus vector expressing the putative mammary oncogene int-1 causes partial transformation of a mammary epithelial cell line. Cell (1986) 2.32
A circadian signal of change of season in patients with seasonal affective disorder. Arch Gen Psychiatry (2001) 2.32
Pathophysiology and prevention of atrial fibrillation. Circulation (2001) 2.31
Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. Hum Mol Genet (1995) 2.30
Multiple mechanisms of Na+ channel--linked long-QT syndrome. Circ Res (1996) 2.29
Alteration and restoration of K+ channel function by deletions at the N- and C-termini. Neuron (1990) 2.26
A common polymorphism associated with antibiotic-induced cardiac arrhythmia. Proc Natl Acad Sci U S A (2000) 2.26
The proto-oncogene int-1 encodes a secreted protein associated with the extracellular matrix. EMBO J (1990) 2.25
Sodium current in single heart muscle cells. Nature (1979) 2.19
Patch and whole cell calcium currents recorded simultaneously in snail neurons. J Gen Physiol (1984) 2.17
Molecular determinants of dofetilide block of HERG K+ channels. Circ Res (1998) 2.13
Prognosis in the irritable bowel syndrome: a 5-year prospective study. Lancet (1987) 2.13
A comparison of calcium currents in rat and guinea pig single ventricular cells. Circ Res (1984) 2.12
Increased chloride conductance as the proximate cause of hydrogen ion concentration effects in Aplysia neurons. J Gen Physiol (1970) 2.09
Normalization of current kinetics by interaction between the alpha 1 and beta subunits of the skeletal muscle dihydropyridine-sensitive Ca2+ channel. Nature (1991) 2.09
GAP domains responsible for ras p21-dependent inhibition of muscarinic atrial K+ channel currents. Science (1992) 2.09
The agonist effect of dihydropyridines on Ca channels. Nature (1984) 2.07
Induction of calcium currents by the expression of the alpha 1-subunit of the dihydropyridine receptor from skeletal muscle. Nature (1989) 2.04
Electrical alternation of the T-wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndrome. Am Heart J (1975) 2.03
Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. 5-HT1-like receptors resemble cloned 5-HT1D beta receptors. Circulation (1994) 2.02
Identity of a novel delayed rectifier current from human heart with a cloned K+ channel current. Circ Res (1993) 2.02
Similarity of unitary Ca2+ currents in three different species. Nature (1982) 2.00
Scanning calorimetric study of the thermal unfolding of catabolite activator protein from Escherichia coli in the absence and presence of cyclic mononucleotides. Biochemistry (1988) 2.00
First observation of PeV-energy neutrinos with IceCube. Phys Rev Lett (2013) 2.00
Light response of a giant Aplysia neuron. J Gen Physiol (1973) 1.96
A description of activation and conduction in calcium channels based on tail and turn-on current measurements in the snail. J Physiol (1983) 1.93
K+ pore structure revealed by reporter cysteines at inner and outer surfaces. Neuron (1995) 1.91
Leucine auxotrophy restricts growth of Mycobacterium bovis BCG in macrophages. Infect Immun (1996) 1.89
A sympathetic reflex elicited by experimental coronary occlusion. Am J Physiol (1969) 1.89
Wnt-1 regulation of connexin43 in cardiac myocytes. J Clin Invest (2000) 1.87
Nucleotide sequence and expression in vitro of cDNA derived from mRNA of int-1, a provirally activated mouse mammary oncogene. Mol Cell Biol (1985) 1.85
Specification of pore properties by the carboxyl terminus of inwardly rectifying K+ channels. Science (1994) 1.85
Relapsing experimental allergic encephalomyelitis in the SJL/J mouse. Lab Invest (1981) 1.84
Unified account of the variable effects of carbon dioxide on nerve cells. Science (1970) 1.84
C-terminus determinants for Mg2+ and polyamine block of the inward rectifier K+ channel IRK1. EMBO J (1995) 1.84
Discovery of very-high-energy gamma-rays from the Galactic Centre ridge. Nature (2006) 1.81
The alpha subunit of the GTP binding protein Gk opens atrial potassium channels. Science (1987) 1.79
Coupling of ATP-sensitive K+ channels to A1 receptors by G proteins in rat ventricular myocytes. Am J Physiol (1990) 1.79
The units of calcium conduction in Helix neurones. Nature (1978) 1.78
The long QT syndrome: a prospective international study. Circulation (1985) 1.77
Interaction between calcium ions and surface charge as it relates to calcium currents. J Membr Biol (1983) 1.76
Nonmodal gating of cardiac calcium channels as revealed by dihydropyridines. J Gen Physiol (1989) 1.76
A 5-hydroxytryptamine receptor in human atrium. Br J Pharmacol (1990) 1.76
SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist. Neuropharmacology (1997) 1.76
The mouse Wnt-1 gene can act via a paracrine mechanism in transformation of mammary epithelial cells. Mol Cell Biol (1992) 1.75
Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias. J Cardiovasc Electrophysiol (2000) 1.74
KChAP as a chaperone for specific K(+) channels. Am J Physiol Cell Physiol (2000) 1.73